{"id":"https://openalex.org/W2016503120","doi":"https://doi.org/10.1089/hum.2011.021","title":"In Vitro Primary Cell Culture as a Physiologically Relevant Method for Preclinical Testing of Human Oncolytic Adenovirus","display_name":"In Vitro Primary Cell Culture as a Physiologically Relevant Method for Preclinical Testing of Human Oncolytic Adenovirus","publication_year":2011,"publication_date":"2011-08-08","ids":{"openalex":"https://openalex.org/W2016503120","doi":"https://doi.org/10.1089/hum.2011.021","mag":"2016503120","pmid":"https://pubmed.ncbi.nlm.nih.gov/21823897"},"language":"en","primary_location":{"id":"doi:10.1089/hum.2011.021","doi":"https://doi.org/10.1089/hum.2011.021","is_oa":false,"landing_page_url":"https://doi.org/10.1089/hum.2011.021","pdf_url":null,"source":{"id":"https://openalex.org/S39730559","display_name":"Human Gene Therapy","issn_l":"1043-0342","issn":["1043-0342","1557-7422"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Gene Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://eprints.qut.edu.au/55851/1/adamson_Human_gene_therapy_2012.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005254272","display_name":"Rachel Adamson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"R.E. Adamson","raw_affiliation_strings":["YCR Cancer Research Unit, Department of Biology, University of York, Heslington, York YO10 5DD, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"YCR Cancer Research Unit, Department of Biology, University of York, Heslington, York YO10 5DD, United Kingdom","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111464532","display_name":"Aliaksandra Frazier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A.A. Frazier","raw_affiliation_strings":["Pro-Cure Therapeutics Ltd., York Science Park, York, YO10 5NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pro-Cure Therapeutics Ltd., York Science Park, York, YO10 5NY, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"H. Evans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"H. Evans","raw_affiliation_strings":["YCR Cancer Research Unit, Department of Biology, University of York, Heslington, York YO10 5DD, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"YCR Cancer Research Unit, Department of Biology, University of York, Heslington, York YO10 5DD, United Kingdom","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015579239","display_name":"Karen Chambers","orcid":"https://orcid.org/0000-0002-6216-4794","observed_orcids":["https://orcid.org/0000-0002-6216-4794"]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"K.F. Chambers","raw_affiliation_strings":["YCR Cancer Research Unit, Department of Biology, University of York, Heslington, York YO10 5DD, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"YCR Cancer Research Unit, Department of Biology, University of York, Heslington, York YO10 5DD, United Kingdom","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"middle","author":{"id":null,"display_name":"E. Schenk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"E. Schenk","raw_affiliation_strings":["Department of Urology, Erasmus MC, Rotterdam 3015CE, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Erasmus MC, Rotterdam 3015CE, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004593392","display_name":"Magnus Essand","orcid":"https://orcid.org/0000-0002-9725-0422","observed_orcids":["https://orcid.org/0000-0002-9725-0422"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"M. Essand","raw_affiliation_strings":["Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala SE-75185, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala SE-75185, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Birnie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Birnie","raw_affiliation_strings":["Pro-Cure Therapeutics Ltd., York Science Park, York, YO10 5NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pro-Cure Therapeutics Ltd., York Science Park, York, YO10 5NY, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111790960","display_name":"Ragai R. Mitry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R.R. Mitry","raw_affiliation_strings":["Hepatocyte Biology and Transplantation Group, Institute of Liver Studies, King's College Hospital, London SE5 9RS, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hepatocyte Biology and Transplantation Group, Institute of Liver Studies, King's College Hospital, London SE5 9RS, United Kingdom","institution_ids":["https://openalex.org/I4210153400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029054721","display_name":"Anil Kumar Dhawan","orcid":"https://orcid.org/0000-0002-4942-0845","observed_orcids":["https://orcid.org/0000-0002-4942-0845"]},"institutions":[{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Dhawan","raw_affiliation_strings":["Hepatocyte Biology and Transplantation Group, Institute of Liver Studies, King's College Hospital, London SE5 9RS, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hepatocyte Biology and Transplantation Group, Institute of Liver Studies, King's College Hospital, London SE5 9RS, United Kingdom","institution_ids":["https://openalex.org/I4210153400"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056647005","display_name":"Norman J. Maitland","orcid":"https://orcid.org/0000-0003-1607-9035","observed_orcids":["https://orcid.org/0000-0003-1607-9035"]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"N.J. Maitland","raw_affiliation_strings":["Pro-Cure Therapeutics Ltd., York Science Park, York, YO10 5NY, United Kingdom","YCR Cancer Research Unit, Department of Biology, University of York, Heslington, York YO10 5DD, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pro-Cure Therapeutics Ltd., York Science Park, York, YO10 5NY, United Kingdom","institution_ids":[]},{"raw_affiliation_string":"YCR Cancer Research Unit, Department of Biology, University of York, Heslington, York YO10 5DD, United Kingdom","institution_ids":["https://openalex.org/I52099693"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5005254272"],"corresponding_institution_ids":["https://openalex.org/I52099693"],"apc_list":null,"apc_paid":null,"fwci":0.7449,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.70147269,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"23","issue":"2","first_page":"218","last_page":"230"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11048","display_name":"Bacteriophages and microbial interactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2303","display_name":"Ecology"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-adenovirus","display_name":"oncolytic adenovirus","score":0.9860000014305115},{"id":"https://openalex.org/keywords/primary-human-cells","display_name":"primary human cells","score":0.7200000286102295},{"id":"https://openalex.org/keywords/hepatocytes","display_name":"hepatocytes","score":0.8830000162124634},{"id":"https://openalex.org/keywords/coxsackie-adenovirus-receptor","display_name":"coxsackievirus and adenovirus receptor","score":0.8970000147819519},{"id":"https://openalex.org/keywords/viral-cytotoxicity","display_name":"viral cytotoxicity","score":0.7770000100135803},{"id":"https://openalex.org/keywords/preclinical-safety-evaluation","display_name":"preclinical safety","score":0.6890000104904175}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.7801563739776611},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6650458574295044},{"id":"https://openalex.org/C2777283488","wikidata":"https://www.wikidata.org/wiki/Q7095181","display_name":"Oncolytic adenovirus","level":4,"score":0.5676824450492859},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4980320930480957},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4903578758239746},{"id":"https://openalex.org/C2993684226","wikidata":"https://www.wikidata.org/wiki/Q2662727","display_name":"Human cell","level":3,"score":0.46541714668273926},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4192591905593872},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.35041290521621704},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.23743361234664917},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12195560336112976}],"mesh":[{"descriptor_ui":"D000260","descriptor_name":"Adenoviruses, Human","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004847","descriptor_name":"Epithelial Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004847","descriptor_name":"Epithelial Cells","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009928","descriptor_name":"Organ Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D014764","descriptor_name":"Viral Proteins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D022781","descriptor_name":"Hepatocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D022781","descriptor_name":"Hepatocytes","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D042783","descriptor_name":"Endothelial Cells","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046529","descriptor_name":"Microscopy, Electron, Transmission","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050130","descriptor_name":"Oncolytic Virotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D050504","descriptor_name":"Oncolytic Viruses","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061251","descriptor_name":"Primary Cell Culture","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062727","descriptor_name":"Coxsackie and Adenovirus Receptor-Like Membrane Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D062727","descriptor_name":"Coxsackie and Adenovirus Receptor-Like Membrane Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1089/hum.2011.021","doi":"https://doi.org/10.1089/hum.2011.021","is_oa":false,"landing_page_url":"https://doi.org/10.1089/hum.2011.021","pdf_url":null,"source":{"id":"https://openalex.org/S39730559","display_name":"Human Gene Therapy","issn_l":"1043-0342","issn":["1043-0342","1557-7422"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Gene Therapy","raw_type":"journal-article"},{"id":"pmid:21823897","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21823897","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human gene therapy","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.qut.edu.au:55851","doi":null,"is_oa":true,"landing_page_url":"https://eprints.qut.edu.au/55851/1/adamson_Human_gene_therapy_2012.pdf","pdf_url":"https://eprints.qut.edu.au/55851/1/adamson_Human_gene_therapy_2012.pdf","source":{"id":"https://openalex.org/S4306402607","display_name":"QUT ePrints (Queensland University of Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I160993911","host_organization_name":"Queensland University of Technology","host_organization_lineage":["https://openalex.org/I160993911"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Human Gene Therapy","raw_type":"Contribution to Journal"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/767117fe-b277-41ce-b82b-54b32c27d3b6","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/767117fe-b277-41ce-b82b-54b32c27d3b6","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Adamson, R E, Frazier, A A, Evans, H, Chambers, K F, Schenk, E, Essand, M, Birnie, R, Mitry, R R, Dhawan, A & Maitland, N J 2012, 'In Vitro Primary Cell Culture as a Physiologically Relevant Method for Preclinical Testing of Human Oncolytic Adenovirus', Human Gene Therapy, vol. 23, no. 2, pp. 218 - 230. https://doi.org/10.1089/hum.2011.021","raw_type":"info:eu-repo/semantics/publishedVersion"}],"best_oa_location":{"id":"pmh:oai:eprints.qut.edu.au:55851","doi":null,"is_oa":true,"landing_page_url":"https://eprints.qut.edu.au/55851/1/adamson_Human_gene_therapy_2012.pdf","pdf_url":"https://eprints.qut.edu.au/55851/1/adamson_Human_gene_therapy_2012.pdf","source":{"id":"https://openalex.org/S4306402607","display_name":"QUT ePrints (Queensland University of Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I160993911","host_organization_name":"Queensland University of Technology","host_organization_lineage":["https://openalex.org/I160993911"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Human Gene Therapy","raw_type":"Contribution to Journal"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7192384560","display_name":null,"funder_award_id":"512087","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"}],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2016503120.pdf","grobid_xml":"https://content.openalex.org/works/W2016503120.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1579265529","https://openalex.org/W1808107661","https://openalex.org/W1943398466","https://openalex.org/W1969658796","https://openalex.org/W1970247544","https://openalex.org/W1974600730","https://openalex.org/W1978998479","https://openalex.org/W2014840020","https://openalex.org/W2034324302","https://openalex.org/W2036048598","https://openalex.org/W2040057733","https://openalex.org/W2043400006","https://openalex.org/W2045442386","https://openalex.org/W2048279620","https://openalex.org/W2053981403","https://openalex.org/W2085649860","https://openalex.org/W2113534698","https://openalex.org/W2122669148","https://openalex.org/W2129215415","https://openalex.org/W2133916339","https://openalex.org/W2138863592","https://openalex.org/W2141433188","https://openalex.org/W2158998850","https://openalex.org/W2318649714","https://openalex.org/W4253422011"],"related_works":["https://openalex.org/W1982154510","https://openalex.org/W2156653943","https://openalex.org/W2397188895","https://openalex.org/W2015239007","https://openalex.org/W1966669827","https://openalex.org/W2027873259","https://openalex.org/W2040057733","https://openalex.org/W2045596296","https://openalex.org/W1641036275","https://openalex.org/W2130515002"],"abstract_inverted_index":{"Ad[I/PPT-E1A]":[0,42,69,86,125,150,176],"is":[1,309],"an":[2,112,269],"oncolytic":[3,21,255,282],"adenovirus":[4,193,283],"that":[5,110,171],"specifically":[6],"kills":[7],"prostate":[8,207,211,285,315],"cells":[9,82,208,224,240],"via":[10],"restricted":[11],"replication":[12,19,46,94,199,308],"by":[13,97],"a":[14,29,234,242,280],"prostate-specific":[15],"regulatory":[16],"element.":[17],"Off-target":[18],"of":[20,38,41,63,115,117,149,155,175,191,220,230,237,252,279,304],"adenoviruses":[22,256],"would":[23],"have":[24],"serious":[25],"clinical":[26],"consequences.":[27],"As":[28],"proposed":[30],"ex":[31],"vivo":[32,66],"test,":[33],"we":[34],"describe":[35],"the":[36,39,61,133,140,153,172,204,221,228,250,275],"assessment":[37],"specificity":[40,229,251,278],"viral":[43,87,93,104,184,198,307],"cytotoxicity":[44,88],"and":[45,79,92,209,214,244,260,277],"in":[47,65,89,123,132,152,177,203,218,257,292,312],"human":[48,178,239,263],"nonprostate":[49,54,134,223,264],"primary":[50,53,135,179,206,238,265,314],"cells.":[51,157,286],"Four":[52],"cell":[55,136,212,266],"types":[56,137,225],"were":[57,83],"selected":[58],"to":[59,68,102,120,183,273],"mimic":[60],"effects":[62,131,174,289],"potential":[64],"exposure":[67],"virus:":[70],"bronchial":[71],"epithelial":[72],"cells,":[73,75,78,298,316],"urothelial":[74],"vascular":[76,296],"endothelial":[77,297],"hepatocytes.":[80,141],"Primary":[81],"analyzed":[84],"for":[85,167,248],"MTS":[90],"assays,":[91],"was":[95,200,215],"determined":[96],"hexon":[98,105],"titer":[99],"immunostaining":[100],"assays":[101],"quantify":[103],"protein.":[106,196],"The":[107],"results":[108],"revealed":[109,146],"at":[111,300],"extreme":[113],"multiplicity":[114,303],"infection":[116],"500,":[118],"unlikely":[119],"be":[121],"achieved":[122],"vivo,":[124],"virus":[126],"showed":[127,164],"no":[128,165],"significant":[129],"cytotoxic":[130,173,288],"apart":[138],"from":[139],"Transmission":[142],"electron":[143],"microscopy":[144],"studies":[145,163],"high":[147,302],"levels":[148],"sequestered":[151],"cytoplasm":[154],"these":[156],"Adenoviral":[158],"green":[159],"fluorescent":[160],"protein":[161],"reporter":[162],"evidence":[166],"nuclear":[168],"localization,":[169],"suggesting":[170],"hepatocytes":[180,187],"are":[181,290],"related":[182],"sequestration.":[185],"Also,":[186],"had":[188],"increased":[189],"amounts":[190],"coxsackie":[192],"receptor":[194],"surface":[195],"Active":[197,306],"only":[201,311],"observed":[202,310],"permissive":[205,313],"LNCaP":[210],"line,":[213],"not":[216],"evident":[217],"any":[219],"other":[222],"tested,":[226],"confirming":[227,317],"Ad[I/PPT-E1A].":[231],"Thus,":[232],"using":[233],"relevant":[235],"panel":[236],"provides":[241],"convenient":[243],"alternative":[245,270],"preclinical":[246,271],"assay":[247],"examining":[249],"conditionally":[253],"replicating":[254],"vivo.":[258],"Adamson":[259],"colleagues":[261],"use":[262],"cultures":[267],"as":[268],"method":[272],"assess":[274],"safety":[276],"conditional":[281],"targeting":[284],"No":[287],"seen":[291],"bronchial,":[293],"urothelial,":[294],"or":[295],"even":[299],"extremely":[301],"infection.":[305],"vector":[318],"specificity.":[319]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}